Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company was founded in 1988 and is based in Hyderabad, India.
| Current Price | ₹587.25 |
|---|---|
| Market Cap | ₹0 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 134.7 |
| 52-Week Range | ₹400.00 – ₹706.00 |
Sai Parenteral's Limited is trading at ₹587.25, with a market capitalisation of ₹0 Cr.
Sai Parenteral's Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Medicinal Chemicals and Botanical Products; Pharmaceutical Contract Manufacturing Services).
Sai Parenteral's Limited has a P/E of 134.7.